from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1684/-

LFCtreatmentdescriptionclass of inhibitor

-0.572

Amikacinug/mL Amikacintranslation

-0.103

Cap5-10ug/mL Capreomycintranslation

-0.128

Rox10-50 ug/mL Roxithromycintranslation

0.888

SM2-5 ug/mL Streptomycintranslation

-1.115

Tet5-10 ug/mL Tetracyclinetranslation

-1.616

Rif0.2-5ug/mL Rifampicintranscription

-0.736

Rifp0.1-0.5ug/mL Rifapentinetranscription

-2.404

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.539

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.892

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.489

Clofazimine10-13 ug/mL Clofaziminerespiration

0.522

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.875

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.063

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.626

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.300

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.531

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.448

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.892

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.503

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.688

KCN5-20 ug/mL Potassium cyaniderespiration

0.255

NaN30.2-2 mM Sodium aziderespiration

2.047

Nigericin50 uM Nigericinrespiration

-1.146

TRC10-150 ug/mL Triclosanrespiration

-1.249

TRZ10-25 ug/mL Thioridazinerespiration

0.750

Valinomycin0.5-10 uM Valinomycinrespiration

2.123

ZnSO42 mM ZnSO4respiration

-0.033

menadione6-10 ug/mL Menadionerespiration

-0.888

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.123

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.693

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.496

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.305

NRP_1Non-replicating persistence stage 1dosRassociated

0.554

Amp0.2mg/mL AmpicillincellWall

-0.232

Cephalexin20-100 ug/mL CephalexincellWall

0.052

Cerulenin0.32-5 ug/mL CerulenincellWall

0.303

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.004

EMB10-20 ug/mL EthambutolcellWall

-0.733

Eta12-40 ug/mL EthionamidecellWall

-0.455

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.726

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.096

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.206

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.436

BZA0.12 mg/mL BenzamidearomaticAmides

0.579

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.901

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.587

H2O24 mM hydrogen peroxideDNAdamaging

-0.661

Levo10 ug/mL LevofloxacinDNAdamaging

0.553

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.836

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.538

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.989

UVUV-irradiationDNAdamaging

-1.745

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.054

Antimycin12.5-50 ug/mL Antimycin A?

0.752

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.022

PA_110-50 ug/mL Antitubercular compound PA-1?

0.112

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.901

PA8240.2-2 ug/mL PA-824?

1.065

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.807

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.097

Verapamil50 uM Verapamil?

0.181

mercaptoethanol2 mM 2-Mercaptoethanol?

0.432

methoxatin10-20 ug/mL Methoxatin?